P. Bastard Et Al. , "Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.," The Journal of experimental medicine , vol.221, no.2, 2024
Bastard, P. Et Al. 2024. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.. The Journal of experimental medicine , vol.221, no.2 .
Bastard, P., Gervais, A., Taniguchi, M., Saare, L., Särekannu, K., Le Voyer, T., ... Philippot, Q.(2024). Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.. The Journal of experimental medicine , vol.221, no.2.
Bastard, Paul Et Al. "Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.," The Journal of experimental medicine , vol.221, no.2, 2024
Bastard, Paul Et Al. "Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.." The Journal of experimental medicine , vol.221, no.2, 2024
Bastard, P. Et Al. (2024) . "Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.." The Journal of experimental medicine , vol.221, no.2.
@article{article, author={Paul Bastard Et Al. }, title={Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.}, journal={The Journal of experimental medicine}, year=2024}